Top

BMC Cancer

Published in:

Open Access 01-12-2021 | Research article

Mixed methods assessment of impact on health awareness in adult childhood cancer survivors after viewing their personalized digital treatment summary and follow-up recommendations

Authors: Helena M. Linge, Cecilia Follin

Published in: BMC Cancer | Issue 1/2021

Abstract

Background

The survival rate after childhood cancer has improved to 80%. The majority of childhood cancer survivors (CCS) will experience late complications which require follow up care, including access to their individual cancer treatment summary. The need to understand CCS needs and preferences in terms of ways to receive information e.g. digitally, becomes important. This study aims to through a mixed methods approach a) examine how CCS’ health awareness was impacted by viewing their personalized digital treatment summary and follow-up recommendations, b) explore E health literacy, and c) determine self-reported survivorship experiences and health care usage.

Methods

Survivors with a recent visit to the Late effects clinic were eligible for the study (n = 70). A representative sample of primary diagnoses were invited (n = 28). 16 CCS were enrolled. Recent medical visits, e health literacy and impressions of the digital treatment summary were assessed by a survey in conjunction with viewing their digital treatment summary on a computer screen. Their experience of reading and understanding their digital treatment summary in the context of their health related survivorship experiences were assessed in focus groups. The transcribed data was analyzed with conventional qualitative content analysis.

Results

The self-reported medical problems largely reflected that, only 6,3% reported no cancer-related reasons for seeking medical attention. Of the medical specialists, the primary care physician was the most frequently visited specialist (68.8%). High E health literacy was not associated with treatment features but with educational level (p = 0.003, CI: 3.9–14.6) and sex (p = 0.022, CI: − 13.6- -1.3). All survivors graded the digital treatment summary above average in terms of being valuable, agreeable and comprehensive. The focus group interviews identified three themes: 1) The significance of information, 2) The impact of awareness; and 3) Empowerment.

Conclusions

Reading the treatment summaries furthered the survivors understanding of their health situation and consequently aided empowerment. A digital treatment summary, provided by knowledgeable health care professionals, may increase the self-managed care and adherence to follow-up recommendations. Further insights into e health literacy in larger samples of CCS may determine to what extent health-related information can be communicated via digital resources to this at risk population.

Available only for authorised users

Howlader N, Krapcho M, Neyman N. SEER Cancer Statistics Review 1975-1998.

Olsen JH, Moller T, Anderson H, Langmark F, Sankila R, Tryggvadottir L, et al. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries. J Natl Cancer Inst. 2009;101(11):806–13. https://doi.org/10.1093/jnci/djp104.CrossRefPubMed

Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355(15):1572–82. https://doi.org/10.1056/NEJMsa060185.CrossRefPubMed

Bhakta N, Liu Q, Ness KK, Baassiri M, Eissa H, Yeo F, Chemaitilly W, Ehrhardt MJ, Bass J, Bishop MW, Shelton K, Lu L, Huang S, Li Z, Caron E, Lanctot J, Howell C, Folse T, Joshi V, Green DM, Mulrooney DA, Armstrong GT, Krull KR, Brinkman TM, Khan RB, Srivastava DK, Hudson MM, Yasui Y, Robison LL. The cumulative burden of surviving childhood cancer: an initial report from the St Jude lifetime cohort study (SJLIFE). Lancet. 2017;390(10112):2569–82. https://doi.org/10.1016/S0140-6736(17)31610-0.CrossRefPubMedPubMedCentral

Oeffinger KC, Wallace WH. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer. 2006;46(2):135–42. https://doi.org/10.1002/pbc.20614.CrossRefPubMed

Kadan-Lottick NS, Robison LL, Gurney JG, Neglia JP, Yasui Y, Hayashi R, Hudson M, Greenberg M, Mertens AC. Childhood cancer survivors' knowledge about their past diagnosis and treatment: childhood Cancer survivor study. JAMA. 2002;287(14):1832–9. https://doi.org/10.1001/jama.287.14.1832.CrossRefPubMed

Landier W, Bhatia S, Eshelman DA, Forte KJ, Sweeney T, Hester AL, Darling J, Armstrong FD, Blatt J, Constine LS, Freeman CR, Friedman DL, Green DM, Marina N, Meadows AT, Neglia JP, Oeffinger KC, Robison LL, Ruccione KS, Sklar CA, Hudson MM. Development of risk-based guidelines for pediatric cancer survivors: the Children's oncology group long-term follow-up guidelines from the Children's oncology group late effects committee and nursing discipline. J Clin Oncol. 2004;22(24):4979–90. https://doi.org/10.1200/JCO.2004.11.032.CrossRefPubMed

Krull KR, Annett RD, Pan Z, Ness KK, Nathan PC, Srivastava DK, Stovall M, Robison LL, Hudson MM. Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: a report from the childhood Cancer survivor study. Eur J Cancer. 2011;47(9):1380–8. https://doi.org/10.1016/j.ejca.2011.03.001.CrossRefPubMedPubMedCentral

Pålsson A, Malmstrom M, Follin C. Childhood leukaemia survivors' experiences of long-term follow-ups in an endocrine clinic - a focus-group study. Eur J Oncol Nurs. 2017;26:19–26. https://doi.org/10.1016/j.ejon.2016.10.006.CrossRefPubMed

10.

Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer. 2006;46(2):159–68. https://doi.org/10.1002/pbc.20611.CrossRefPubMed

11.

Absolom K, Greenfield D, Ross R, Horne B, Davies H, Glaser A, Simpson A, Waite H, Eiser C. Predictors of clinic satisfaction among adult survivors of childhood cancer. Eur J Cancer. 2006;42(10):1421–7. https://doi.org/10.1016/j.ejca.2006.01.053.CrossRefPubMed

12.

Cherven B, Mertens A, Meacham LR, Williamson R, Boring C, Wasilewski-Masker K. Knowledge and risk perception of late effects among childhood cancer survivors and parents before and after visiting a childhood cancer survivor clinic. J Pediatr Oncol Nurs. 2014;31(6):339–49. https://doi.org/10.1177/1043454214532022.CrossRefPubMed

13.

Casillas J, Oeffinger KC, Hudson MM, Greenberg ML, Yeazel MW, Ness KK, Henderson TO, Robison LL, Armstrong GT, Liu Q, Leisenring W, Yasui Y, Nathan PC. Identifying predictors of longitudinal decline in the level of medical care received by adult survivors of childhood Cancer: a report from the childhood Cancer survivor study. Health Serv Res. 2015;50(4):1021–42. https://doi.org/10.1111/1475-6773.12282.CrossRefPubMedPubMedCentral

14.

Gibson F, Aslett H, Levitt G, Richardson A. Follow up after childhood cancer: a typology of young people’s health care need. Clin Eff Nurs. 2005;9(3–4):133–46. https://doi.org/10.1016/j.cein.2006.08.005.CrossRef

15.

Earle E, Davies H, Greenfield D, Ross R, Eiser C. Follow-up care for childhood cancer survivors: a focus group analysis. Eur J Cancer. 2005;41(18):2882–6. https://doi.org/10.1016/j.ejca.2005.08.028.CrossRefPubMed

16.

Risling T, Martinez J, Young J, Thorp-Froslie N. Evaluating patient empowerment in association with eHealth technology: scoping review. J Med Internet Res. 2017;19(9):e329. https://doi.org/10.2196/jmir.7809.CrossRefPubMedPubMedCentral

17.

Petersson-Ahrholt M, Wiebe T, Hjorth L, Relander T, Linge HM. Development and implementation of survivorship tools to enable medical follow-up after childhood Cancer treatment in southern Sweden. JCO Clin Cancer Inform. 2019;3:1–6. https://doi.org/10.1200/CCI.18.00130.CrossRefPubMed

18.

Wiebe T, Hjorth L, Marotta Kelly M, Linge HM, Garwicz S. A population based pediatric oncology registry in southern Sweden: the BORISS registry. Eur J Epidemiol. 2018;33(11):1125–9. https://doi.org/10.1007/s10654-018-0437-1.CrossRefPubMedPubMedCentral

19.

McClellan W, Klemp JR, Krebill H, Ryan R, Nelson EL, Panicker J, Sharma M, Stegenga K. Understanding the functional late effects and informational needs of adult survivors of childhood cancer. Oncol Nurs Forum. 2013;40(3):254–62. https://doi.org/10.1188/13.ONF.254-262.CrossRefPubMedPubMedCentral

20.

Gund A, Ekman I, Lindecrantz K, Sjoqvist BA, Staaf EL, Thorneskold N. Design evaluation of a home-based telecare system for chronic heart failure patients. Annu Int Conf IEEE Eng Med Biol Soc. 2008;2008:5851–4. https://doi.org/10.1109/IEMBS.2008.4650545.CrossRefPubMed

21.

Robinson C, Gund A, Sjoqvist BA, Bry K. Using telemedicine in the care of newborn infants after discharge from a neonatal intensive care unit reduced the need of hospital visits. Acta Paediatr. 2016;105(8):902–9. https://doi.org/10.1111/apa.13407.CrossRefPubMedPubMedCentral

22.

Norman CD, Skinner HA. eHEALS: the eHealth literacy scale. J Med Internet Res. 2006;8(4):e27. https://doi.org/10.2196/jmir.8.4.e27.CrossRefPubMedPubMedCentral

23.

Krueger RA, Casey MA. Focus groups: a practical guide for applied research. Thousand Oakes, CA: SAGE publications; 2009.

24.

Milne RA, Puts MT, Papadakos J, Le LW, Milne VC, Hope AJ, et al. Predictors of high eHealth literacy in primary lung Cancer survivors. J Cancer Educ. 2015;30(4):685–92. https://doi.org/10.1007/s13187-014-0744-5.CrossRefPubMed

25.

Park H, Cormier E, Gordon G, Baeg J. Identifying Health Consumers' eHealth Literacy to Decrease Disparities in Accessing eHealth Information. Comput Inform Nurs. 2016;34(2):71.CrossRef

26.

Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277–88. https://doi.org/10.1177/1049732305276687.CrossRefPubMed

27.

Hewitt M, Weiner S, Simone J editors. Childhood Cancer Survivorship: Improving Care and Quality of Life. Washington (DC): National Cancer Policy BoardInstitute of Medicine (US) and National Research Council (US); 2003.

28.

Lie HC, Mellblom AV, Brekke M, Finset A, Fossa SD, Kiserud CE, et al. Experiences with late effects-related care and preferences for long-term follow-up care among adult survivors of childhood lymphoma. Support Care Cancer. 2017;25(8):2445–54. https://doi.org/10.1007/s00520-017-3651-6.CrossRefPubMed

29.

Ramsay JM, Mann K, Kaul S, Zamora ER, Smits-Seemann RR, Kirchhoff AC. Follow-up care provider preferences of adolescent and Young adult Cancer survivors. J Adolesc Young Adult Oncol. 2018;7(2):204–9. https://doi.org/10.1089/jayao.2017.0083.CrossRefPubMedPubMedCentral

30.

Mayes J, Brown MC, Davies N, Skinner R. Health promotion and information provision during long-term follow-up for childhood cancer survivors: a service evaluation. Pediatr Hematol Oncol. 2016;33(6):359–70. https://doi.org/10.1080/08880018.2016.1225325.CrossRefPubMed

31.

Knijnenburg SL, Kremer LC, van den Bos C, Braam KI, Jaspers MW. Health information needs of childhood cancer survivors and their family. Pediatr Blood Cancer. 2010;54(1):123–7. https://doi.org/10.1002/pbc.22207.CrossRefPubMed

32.

Halwas N, Griebel L, Huebner J. eHealth literacy, internet and eHealth service usage: a survey among cancer patients and their relatives. J Cancer Res Clin Oncol. 2017;143(11):2291–9. https://doi.org/10.1007/s00432-017-2475-6.CrossRefPubMed

33.

Escoffery C. Gender Similarities and Differences for e-Health Behaviors Among U.S. Adults. Telemed J E Health. 2018;24(5):335.CrossRef

Title: Mixed methods assessment of impact on health awareness in adult childhood cancer survivors after viewing their personalized digital treatment summary and follow-up recommendations
Authors: Helena M. Linge
Cecilia Follin
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: BMC Cancer / Issue 1/2021
Electronic ISSN: 1471-2407
DOI: https://doi.org/10.1186/s12885-021-08051-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2021

Complex interactions of lovastatin with 10 chemotherapeutic drugs: a rigorous evaluation of synergism and antagonism

ROR1 and ROR2 expression in pancreatic cancer

High HSPA8 expression predicts adverse outcomes of acute myeloid leukemia

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs

Actual long-term survival after resection of stage III soft tissue sarcoma

Risk factors of breast cancer among patients in a tertiary care hospitals in Afghanistan: a case control study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer